196 related articles for article (PubMed ID: 36814925)
21. Combining bulk RNA-sequencing and single-cell RNA-sequencing data to reveal the immune microenvironment and metabolic pattern of osteosarcoma.
Huang R; Wang X; Yin X; Zhou Y; Sun J; Yin Z; Zhu Z
Front Genet; 2022; 13():976990. PubMed ID: 36338972
[No Abstract] [Full Text] [Related]
22. SELPLG Expression Was Potentially Correlated With Metastasis and Prognosis of Osteosarcoma.
Wang B; Sun Y
Pathol Oncol Res; 2022; 28():1610047. PubMed ID: 35153625
[No Abstract] [Full Text] [Related]
23. An integrative analysis of single-cell and bulk transcriptome and bidirectional mendelian randomization analysis identified C1Q as a novel stimulated risk gene for Atherosclerosis.
Cui HK; Tang CJ; Gao Y; Li ZA; Zhang J; Li YD
Front Immunol; 2023; 14():1289223. PubMed ID: 38179058
[TBL] [Abstract][Full Text] [Related]
24. Interaction gene set between osteoclasts and regulatory CD4
Li F; Tang H; Luo X; Li X; Luo K; Liu S; Liang J; Liao S; Zhong C; Zhan X; Wei Q; Feng W; Liu Y
Cancer Sci; 2023 Jul; 114(7):3014-3026. PubMed ID: 37150900
[TBL] [Abstract][Full Text] [Related]
25. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
26. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.
Hill KE; Kelly AD; Kuijjer ML; Barry W; Rattani A; Garbutt CC; Kissick H; Janeway K; Perez-Atayde A; Goldsmith J; Gebhardt MC; Arredouani MS; Cote G; Hornicek F; Choy E; Duan Z; Quackenbush J; Haibe-Kains B; Spentzos D
J Hematol Oncol; 2017 May; 10(1):107. PubMed ID: 28506242
[TBL] [Abstract][Full Text] [Related]
27. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
28. Identification of Prognostic RBPs in Osteosarcoma.
Li B; Fang L; Wang B; Yang Z; Zhao T
Technol Cancer Res Treat; 2021; 20():15330338211004918. PubMed ID: 33754909
[TBL] [Abstract][Full Text] [Related]
29. Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration.
Fu Y; Bao Q; Liu Z; He G; Wen J; Liu Q; Xu Y; Jin Z; Zhang W
Front Cell Dev Biol; 2021; 9():633607. PubMed ID: 33816483
[TBL] [Abstract][Full Text] [Related]
30. Single-cell RNA-seq identification of four differentially expressed survival-related genes by a TARGET: Osteosarcoma database analysis.
Feleke M; Feng W; Rothzerg E; Song D; Wei Q; Kõks S; Wood D; Liu Y; Xu J
Exp Biol Med (Maywood); 2022 Jun; 247(11):921-930. PubMed ID: 35285281
[TBL] [Abstract][Full Text] [Related]
31. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
[TBL] [Abstract][Full Text] [Related]
32. Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma.
Huang X; Wang L; Guo H; Zhang W; Shao Z
Theranostics; 2022; 12(13):5877-5887. PubMed ID: 35966586
[No Abstract] [Full Text] [Related]
33. Comprehensive analysis of angiogenesis pattern and related immune landscape for individual treatment in osteosarcoma.
Liao Z; Li M; Wen G; Wang K; Yao D; Chen E; Liang Y; Xing T; Su K; Liang C; Che Z; Ning Q; Tang J; Yan W; Li Y; Huang L
NPJ Precis Oncol; 2023 Jun; 7(1):62. PubMed ID: 37386055
[TBL] [Abstract][Full Text] [Related]
34. Construction of survival-related co-expression modules and identification of potential prognostic biomarkers of osteosarcoma using WGCNA.
Bian Y; Huang J; Zeng Z; Yao H; Tu J; Wang B; Zou Y; Xie X; Shen J
Ann Transl Med; 2022 Mar; 10(6):296. PubMed ID: 35434042
[TBL] [Abstract][Full Text] [Related]
35. The Prognostic Model Established by the Differential Expression Genes Based on CD8
Chen Y; Yan W; Wang H; Ou Z; Chen H; Huang Z; Yang J; Liu B; Ou F; Zhang H
Mediators Inflamm; 2023; 2023():6563609. PubMed ID: 36816742
[TBL] [Abstract][Full Text] [Related]
36. [Characterization of Cell Subsets Associated With Prognosis of Osteosarcoma Based on Single-Cell Sequencing Data].
Wang ST; Zhu HR; Xu SJ; Gui P; Chen MZ; Li ZX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):773-782. PubMed ID: 37927019
[TBL] [Abstract][Full Text] [Related]
37. Construction and Validation of a Macrophage-Associated Risk Model for Predicting the Prognosis of Osteosarcoma.
Xiao KW; Liu ZB; Zeng ZH; Yan FF; Xiao LF; Li JL; Cai L
J Oncol; 2021; 2021():9967954. PubMed ID: 34188683
[TBL] [Abstract][Full Text] [Related]
38. Identification of HBEGF+ fibroblasts in the remission of rheumatoid arthritis by integrating single-cell RNA sequencing datasets and bulk RNA sequencing datasets.
Chen N; Fan B; He Z; Yu X; Wang J
Arthritis Res Ther; 2022 Sep; 24(1):215. PubMed ID: 36068607
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
Yang H; Zhao L; Zhang Y; Li FF
Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
[TBL] [Abstract][Full Text] [Related]
40. Identification of key serum biomarkers for the diagnosis and metastatic prediction of osteosarcoma by analysis of immune cell infiltration.
Chen Z; Li L; Li Z; Wang X; Han M; Gao Z; Wang M; Hu G; Xie X; Du H; Xie Z; Zhang H
Cancer Cell Int; 2022 Feb; 22(1):78. PubMed ID: 35151325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
